THDBH-100

N/A

Report date: 2022/03/07 16:01:53
NME

Base Information

Drug NameTHDBH-100
Drug Alias NameTHDBH100THDBH101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitorsSodium/glucose cotransporter 2 inhibitorsDipeptidyl peptidase IV inhibitors
TargetsSodium/glucose cotransporter 1Sodium/glucose cotransporter 2Dipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Apptec(Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDongbao Zixing (Hangzhou) Biological Medicine Co LtdWuxi Apptec(Shanghai) Co LtdTonghua Dongbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A